Sugammadex sodium - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for sugammadex sodium and what is the scope of patent protection?

Sugammadex sodium is the generic ingredient in one branded drug marketed by Organon Sub Merck and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Sugammadex sodium has fifty-six patent family members in thirty countries.

There are two drug master file entries for sugammadex sodium. One supplier is listed for this compound.

Summary for sugammadex sodium

International Patents:	56
US Patents:	3
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	2
Suppliers / Packagers:	1
Bulk Api Vendors:	12
Clinical Trials:	6
Formulation / Manufacturing:	see details
DailyMed Link:	sugammadex sodium at DailyMed

Recent Clinical Trials for sugammadex sodium

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Ministry of Food and Drug Safety, Korea	Phase 2
Seoul National University Hospital	Phase 2
University Health Network, Toronto	Phase 4

See all sugammadex sodium clinical trials

Pharmacology for sugammadex sodium

Synonyms for sugammadex sodium

1202253-72-2
343306-71-8
343306-79-6
361LPM2T56
862667-16-1
AC-30384
Bridion
Bridion (TN)
CHEBI:90952
CHEBI:90953
D05940
DB06206
ERJ6X2MXV7
EX-A2600
gamma-Cyclodextrin, 6A,6B,6C,6D,6E,7F,6G,6H-octakis-S-(2-carboxyethyl)-6A,6B,6C,6D,6E,7F,6G,6H-octathio-, octasodium salt
MK-8616
Octasodium 6,6',6'',6''',6'''',6''''',6'''''',6'''''''-octakis-S-(2-carboxylatoethyl)-6,6',6'',6''',6'''',6''''',6'''''',6'''''''-octathiocyclo-alpha-(1-4)-D-octaglucopyranoside
Org 25969
ORG-25969
SCH-900616
SCHEMBL13917069
Sugammadex
Sugammadex [USAN:INN:BAN]
Sugammadex sodium (JAN/USAN)
Sugammadex sodium [USAN:JAN]
UNII-361LPM2T56
UNII-ERJ6X2MXV7

US Patents and Regulatory Information for sugammadex sodium

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Organon Sub Merck	BRIDION	sugammadex sodium	SOLUTION;INTRAVENOUS	022225-001	Dec 15, 2015		RX	Yes	Yes	Start Trial	Start Trial				Start Trial
Organon Sub Merck	BRIDION	sugammadex sodium	SOLUTION;INTRAVENOUS	022225-001	Dec 15, 2015		RX	Yes	Yes	Start Trial	Start Trial				Start Trial
Organon Sub Merck	BRIDION	sugammadex sodium	SOLUTION;INTRAVENOUS	022225-002	Dec 15, 2015		RX	Yes	No	Start Trial	Start Trial				Start Trial
Organon Sub Merck	BRIDION	sugammadex sodium	SOLUTION;INTRAVENOUS	022225-002	Dec 15, 2015		RX	Yes	No	Start Trial	Start Trial				Start Trial
Organon Sub Merck	BRIDION	sugammadex sodium	SOLUTION;INTRAVENOUS	022225-002	Dec 15, 2015		RX	Yes	No	Start Trial	Start Trial	Y	Y		Start Trial
Organon Sub Merck	BRIDION	sugammadex sodium	SOLUTION;INTRAVENOUS	022225-002	Dec 15, 2015		RX	Yes	No	Start Trial	Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for sugammadex sodium

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
China	1241576	Start Trial
Brazil	0013126	Start Trial
Slovakia	286282	Start Trial
Luxembourg	91501	Start Trial
Japan	4782334	Start Trial
South Africa	200203538	Start Trial
>Country	>Patent Number	>Estimated Expiration

Supplementary Protection Certificates for sugammadex sodium

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1259550	340	Finland	Start Trial
1259550	SZ 47/2008	Austria	Start Trial	PRODUCT NAME: SUGAMMADEX; 6-PER-DEOXY-6-PER-(2-CARBOXYETHYL) THIO-Y-CYCLODEXTRIN UND PHARMAZEUTISCH VERTRÄGLICHES SALZ HIERVON
1259550	C01259550/01	Switzerland	Start Trial	FUSION; FORMER OWNER: ORGANON BIO SCIENCES NEDERLAND B.V., NL
1259550	CA 2009 00002	Denmark	Start Trial	PRODUCT NAME: SUGAMMADEX ELLER FARMACEUTISK AKTIVE SALTE ELLER ESTERE DERAF, HERUNDER SUGAMMADEXNATRIUM
1259550	SPC031/2008	Ireland	Start Trial	SPC031/2008: 20090428, EXPIRES: 20230724
1259550	122008000068	Germany	Start Trial	PRODUCT NAME: SUGAMMADEX ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ DAVON; REGISTRATION NO/DATE: EU/1/08/466/001-002 20080725
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.